Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1996
06/11/1996US5525715 Codes specific polypeptide; useful vaccine to immunize human infected from polio virus
06/11/1996US5525714 Mutated form of the β-amyloid precursor protein gene
06/11/1996US5525713 DNA encoding polypeptides enabling sorting of proteins to vacuoles in plants
06/11/1996US5525712 DNA encoding the human neurokinin-1 receptor
06/11/1996US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells
06/11/1996US5525705 Regulate fat tissue
06/11/1996US5525592 From stingray
06/11/1996US5525524 Assay for determining amount or presence of a target hapten which competes (for binding to its specific receptor) with at least one analogue on a conjugate in a reaction mixture
06/11/1996US5525523 Binding method for FK-506- and rapamycin-like drugs with a novel immunophilin
06/11/1996US5525519 Precipitating with a ph adjusted solution of polyoxyethylene glycol and polyvinylpyrrolidone
06/11/1996US5525508 Purified antigen derived from homogenizing nematodes, extracting and chromatographing on wheat-germ lectin sepharose column
06/11/1996US5525504 Cytolysin gene and gene product
06/11/1996US5525503 Signal transduction via CD28
06/11/1996US5525502 DNA encoding chitin deacetylase
06/11/1996US5525495 Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation
06/11/1996US5525492 Polymerase chain reaction of nucleic acids
06/11/1996US5525490 Yeast cell analysis to screen for molecules that can inhibit protein-protein complexes
06/11/1996US5525489 Antipertussis vaccines
06/11/1996US5525488 Nonchromosomal dna encoding inhibin alpha chain polypeptide having specified sequence
06/11/1996US5525487 DNA encoding I-CAM related protein
06/11/1996US5525486 Genetic engineering
06/11/1996US5525484 Genetically engineered bacteria or yeast cells containing genetic material from recombinant dna which codes for bovine rennin
06/11/1996US5525474 Immunoassay; linking the haptenic drug via its maleimide moiety and a sulfhydryl bridge to an immunogenic carrier to stimulate antibodies
06/11/1996US5525472 Mixing neutralized fatty acids, triglycerides or monoglycerides into escherichia cultures, then cell lysis in presence of magnesium ions and treatment of insoluble recovered material with nonionic detergents
06/11/1996US5525468 Assay for Ribozyme target site
06/11/1996US5525467 Detection, diagnosis, therapy of alzheimer's disease
06/11/1996US5525339 Presence in circulating bodily fluids provides diagnostic mechanism to determine onset of cerebral amyloid plaque formation
06/11/1996US5525336 Cosmetic containing comeocyte proteins and transglutaminase, and method of application
06/11/1996EP0722489A4 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
06/11/1996CA2005950C Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
06/11/1996CA1338395C Pharmaceutical containing tissue protein pp4, a process for the pasteurization of pp4, and the use of pp4
06/11/1996CA1338381C Minactivin - (plasminogen activator inhibitor-2)
06/07/1996WO1996017869A2 Interleukin-6 (il-6) antagonists
06/07/1996CA2177837A1 Interleukin-6 (il-6) antagonists
06/07/1996CA2141708A1 Nucleotide sequences encoding a novel stem cell marker protein, amino acid sequences of the protein, methods for expressing the protein, a composition of isolated protein, and antibodies specific to the protein
06/06/1996WO1996017081A1 Assessment for treatment with neuroleptic agents
06/06/1996WO1996017080A1 Detecting tumours
06/06/1996WO1996017073A1 Process for producing transformed cell
06/06/1996WO1996017072A2 Recombinant alphavirus vectors
06/06/1996WO1996017071A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors
06/06/1996WO1996017068A2 Pathogen-resistant plants and method for producing them
06/06/1996WO1996017067A1 Method for secreting thrombopoietin polypeptides
06/06/1996WO1996017065A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
06/06/1996WO1996017064A1 Phenylalanine free proteins
06/06/1996WO1996017063A1 Plasmids suitable for il-2 expression
06/06/1996WO1996017062A1 Low molecular weight thrombopoietin
06/06/1996WO1996017061A1 An sh3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof
06/06/1996WO1996017060A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies
06/06/1996WO1996017059A2 Receptor for cell-binding domain of thrombospondins
06/06/1996WO1996017058A1 Denatured low-density lipoprotein receptor
06/06/1996WO1996017057A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage
06/06/1996WO1996017056A1 Hypermutagenesis
06/06/1996WO1996017055A1 Carrier protein driven crystallization of a peptide or polypeptide
06/06/1996WO1996016989A1 p53 PROTEINS WITH ALTERED TETRAMERIZATION DOMAINS
06/06/1996WO1996016988A1 Reagents and processes for targeting mutant epidermal growth factor receptors
06/06/1996WO1996016987A1 Thrombocytotic factor
06/06/1996WO1996016986A1 Mel-cam ligand and its use
06/06/1996WO1996016985A1 Passive transfer immune serum and method of making
06/06/1996WO1996016984A1 One step preparation method for nef proteins
06/06/1996WO1996016983A1 Cooperative combinations of ligands contained within a matrix
06/06/1996WO1996016982A2 Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
06/06/1996WO1996016979A1 Expressed chemokines, their production and uses
06/06/1996WO1996016975A1 Diagnosis of and therapy for hereditary haemorrhagic telangiectasia
06/06/1996WO1996016950A1 Hiv protease inhibitors
06/06/1996WO1996016714A1 Method and device for separating fibrin monomer from blood plasma
06/06/1996WO1996016671A1 New antithrombotic formulation, process for its manufacturing, and use thereof
06/06/1996WO1996016668A1 Novel hedgehog-derived polypeptides
06/06/1996WO1996016665A1 Cd40 associated proteins
06/06/1996WO1996016542A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
06/06/1996CA2206610A1 Purified genes encoding mammalian cell surface antigens; proteins and antibodies
06/06/1996CA2206574A1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors
06/06/1996CA2206553A1 Receptor for cell-binding domain of thrombospondins
06/06/1996CA2206496A1 Thrombocytotic factor
06/06/1996CA2206459A1 New antithrombotic formulation, process for its manufacturing, and use thereof
06/06/1996CA2206441A1 Cd40 associated proteins
06/06/1996CA2206305A1 Sox-9 gene and protein and use in the regeneration of bone or cartilage
06/06/1996CA2206175A1 Cooperative combinations of ligands contained within a matrix
06/06/1996CA2206113A1 Expressed chemokines, their production and uses
06/06/1996CA2205964A1 Diagnosis of and therapy for hereditary haemorrhagic telangiectasia
06/06/1996CA2204920A1 New 17-kda brucella abortus antigen, recombinant polypeptides, nucleic acids for coding for the same and use thereof in diagnostic and prophylactic methods and kits
06/06/1996CA2164402A1 Dna primer and a method for screening dnas
06/05/1996EP0714982A2 Hybrid proteins with fibrinolytic and thrombin inhibiting activity
06/05/1996EP0714981A2 PRLTS proteins and DNA's encoding the same
06/05/1996EP0714980A1 Hypermutagenesis
06/05/1996EP0714912A2 GMP-140 derived lektin-like domain peptides and their ligands
06/05/1996EP0714911A2 Somastotatin analogs containing chelating groups and their radiolabeled compositions
06/05/1996EP0714910A1 Use of a decapeptide with a benzodiazepine activity for the preparation of medicaments and dietary supplements
06/05/1996EP0714909A1 Composition for prophylaxis or treatment of pulmonary circulatory diseases
06/05/1996EP0714903A1 New carbohydrate conjugates as cell adhesion inhibitors
06/05/1996EP0714665A2 Osteogenic devices
06/05/1996EP0714662A1 Antiallergic agent
06/05/1996EP0714513A1 Molecular clones producing recombinant dna antigens of the hards virus
06/05/1996EP0714510A1 Natural killer cell-specific antigen and antibodies that identify the same
06/05/1996EP0714449A1 Oligonucleotide modulation of protein kinase c
06/05/1996EP0714446A1 Chitinase, dna coding therefor and plants containing same
06/05/1996EP0714444A1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
06/05/1996EP0714443A1 Detection and prevention of mycoplasma hominis infection
06/05/1996EP0714442A1 Recombinant alternaria alternata allergenes
06/05/1996EP0714441A1 Recombinant cladosporium herbarum allergens
06/05/1996EP0714440A1 T cell epitopes of ryegrass pollen allergen
1 ... 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 2560 2561 ... 2916